Senescence, immune microenvironment, and vascularization in cardiac myxomas
- 1 May 2021
- journal article
- research article
- Published by Elsevier in Cardiovascular Pathology
- Vol. 52, 107335
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Tissue damage and senescence provide critical signals for cellular reprogramming in vivoScience, 2016
- p16 and p53 expression status in head and neck squamous cell carcinoma: a correlation with histological, histoprognostic and clinical parametersPathology, 2016
- Macrophages: An Inflammatory Link Between Angiogenesis and LymphangiogenesisMicrocirculation, 2015
- Understanding high endothelial venules: Lessons for cancer immunologyOncoImmunology, 2015
- The mysterious pathways of cardiac myxomas: a review of histogenesis, pathogenesis and pathologyHistopathology, 2014
- The role of mast cell tryptases in cardiac myxoma: Histogenesis and development of a challenging tumorOncology Letters, 2014
- Cardiac myxoma induced paraneoplastic syndromes: A review of the literatureEuropean Journal of Internal Medicine, 2012
- Blocking lymphotoxin signaling abrogates the development of ectopic lymphoid tissue within cardiac allografts and inhibits effector antibody responsesThe FASEB Journal, 2011
- p16Ink4a overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumorsOncogene, 2011
- Endothelial L-Selectin Ligands Are Likely to Recruit Lymphocytes into Rejecting Human Heart TransplantsThe American Journal of Pathology, 1999